A short-chain fatty acid triad in pain regulation

Luis Rodríguez-Cortés , Rodrigo Pacheco

Exploration of Neuroprotective Therapy ›› 2026, Vol. 6 ›› Issue (1) : 1004151

PDF (1113KB)
Exploration of Neuroprotective Therapy ›› 2026, Vol. 6 ›› Issue (1) :1004151 DOI: 10.37349/ent.2026.1004151
Perspective
research-article
A short-chain fatty acid triad in pain regulation
Author information +
History +
PDF (1113KB)

Abstract

Short-chain fatty acids (SCFAs) are microbial-derived metabolites produced primarily through the fermentation of dietary fibre by the intestinal microbiota. Current evidence indicates that they play a key role in modulating nociception and pain processing across immune, metabolic, and neural pathways. The prevailing view that SCFAs suppress pain has been challenged by emerging evidence demonstrating that these same metabolites can also drive hyperalgesia. This apparent “SCFA paradox” persists because most studies have examined individual metabolites in isolation rather than considering them within their broader biological context. Here, we propose an integrative framework in which SCFAs function within a competitive receptor triad, and pain outcomes are dictated by the balance among three signalling axes: a pro-inflammatory immune axis driven by acetate acting through G protein-coupled receptor 43 (GPR43), a pro-resolutive metabolic axis mediated by butyrate via histone deacetylase (HDAC) inhibition and activation of GPR109A, and a direct neural sensing axis triggered by propionate through olfactory receptor 78 (OLFR78). Chronic pain, therefore, does not arise simply from the presence or absence of SCFAs, but from the pathological dominance of one of these axes shaped by specific dysbiosis profiles. This framework moves beyond correlation by providing a mechanistic basis for precision interventions designed to rebalance SCFA signalling, offering novel therapeutic opportunities for neuropathic and inflammatory pain conditions.

Keywords

gut-brain axis / neuroimmune communication / short-chain fatty acids receptors / nociceptor sensitization

Cite this article

Download citation ▾
Luis Rodríguez-Cortés, Rodrigo Pacheco. A short-chain fatty acid triad in pain regulation. Exploration of Neuroprotective Therapy, 2026, 6 (1) : 1004151 DOI:10.37349/ent.2026.1004151

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Jiang Y, Huang Z, Sun W, Huang J, Xu Y, Liao Y, et al. Roseburia intestinalis-derived butyrate alleviates neuropathic pain. Cell Host Microbe. 2025; 33: 104-18.e7.

[2]

Long X, Li M, Li LX, Sun YY, Zhang WX, Zhao DY, et al. Butyrate promotes visceral hypersensitivity in an IBS-like model via enteric glial cell-derived nerve growth factor. Neurogastroenterol Motil. 2018; 30: e13227.

[3]

Lanza M, Filippone A, Ardizzone A, Casili G, Paterniti I, Esposito E, et al. SCFA Treatment Alleviates Pathological Signs of Migraine and Related Intestinal Alterations in a Mouse Model of NTG-Induced Migraine. Cells. 2021; 10: 2756.

[4]

Zhou F, Wang X, Han B, Tang X, Liu R, Ji Q, et al. Short-chain fatty acids contribute to neuropathic pain via regulating microglia activation and polarization. Mol Pain. 2021; 17: 1744806921996520.

[5]

Sun C, Li A, Wang H, Ma J, Hou J. Positive Regulation of Acetate in Adipocyte Differentiation and Lipid Deposition in Obese Mice. Nutrients. 2023; 15: 3736.

[6]

Prado C, Espinoza A, Martínez-Hernández JE, Petrosino J, Riquelme E, Martin AJM, et al. GPR43 stimulation on TCRαβ+ intraepithelial colonic lymphocytes inhibits the recruitment of encephalitogenic T-cells into the central nervous system and attenuates the development of autoimmunity. J Neuroinflammation. 2023; 20: 135.

[7]

Vinolo MA, Rodrigues HG, Nachbar RT, Curi R. Regulation of inflammation by short chain fatty acids. Nutrients. 2011; 3: 858-76.

[8]

Zhao M, Zhang L, Liu Z. Gut microbiota-mediated pain sensitization: mechanisms and therapeutic implications. Front Pain Res (Lausanne). 2025; 6: 1626515.

[9]

Takeda M, Sashide Y, Utugi S. Neurophysiological Basis of Short-Chain Fatty Acid Action in Pain Modulation: Therapeutic Implications. Int J Mol Sci. 2025; 26: 8082.

[10]

Pang S, Ren Z, Ding H, Chan P. Short-chain fatty acids mediate enteric and central nervous system homeostasis in Parkinson’s disease: Innovative therapies and their translation. Neural Regen Res. 2026; 21: 938-56.

[11]

Pluznick JL, Protzko RJ, Gevorgyan H, Peterlin Z, Sipos A, Han J, et al. Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation. Proc Natl Acad Sci U S A. 2013; 110: 4410-5.

[12]

Taing K, Chen L, Weng HR. Emerging roles of GPR109A in regulation of neuroinflammation in neurological diseases and pain. Neural Regen Res. 2023; 18: 763-8.

[13]

Martin-Gallausiaux C, Marinelli L, Blottière HM, Larraufie P, Lapaque N. SCFA: mechanisms and functional importance in the gut. Proc Nutr Soc. 2021; 80: 37-49.

[14]

Choo C, Mahurkar-Joshi S, Dong TS, Lenhart A, Lagishetty V, Jacobs JP, et al. Colonic mucosal microbiota is associated with bowel habit subtype and abdominal pain in patients with irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2022; 323: G134-43.

[15]

Lan Z, Wei Y, Yue K, He R, Jiang Z. Genetically predicted immune cells mediate the association between gut microbiota and neuropathy pain. Inflammopharmacology. 2024; 32: 3357-73.

[16]

Wang EJ, Karri J, Tontisirin N, Cohen SP. Antimicrobial therapies for chronic pain (part 1): analgesic mechanisms. Korean J Pain. 2023; 36: 281-98.

[17]

Schlatterer K, Beck C, Schoppmeier U, Peschel A, Kretschmer D. Acetate sensing by GPR43 alarms neutrophils and protects from severe sepsis. Commun Biol. 2021; 4: 928.

[18]

Li Y-J, Li J, Dai C. Butyrate promotes visceral hypersensitivity in IBS model via mast cell-derived DRG neuron lincRNA-01028-PKC-TRPV1 pathway. mBio. 2024; 15: e01533-24.

[19]

Huang C, Du W, Ni Y, Lan G, Shi G. The effect of short-chain fatty acids on M2 macrophages polarization in vitro and in vivo. Clin Exp Immunol. 2022; 207: 53-64.

[20]

Hu Y, Yang Y, Li Y, Zhang Q, Zhang W, Jia J, et al. Th17/Treg imbalance in inflammatory bowel disease: immunological mechanisms and microbiota-driven regulation. Front Immunol. 2025; 16: 1651063.

[21]

Zhai J, Li Y, Liu J, Dai C. Neuroimmune interactions: The bridge between inflammatory bowel disease and the gut microbiota. Clin Transl Med. 2025; 15: e70329.

[22]

Sun N, Cao LS, Xia WY, Wang JM, Wu QF. Gut sensory neurons as regulators of neuro-immune-microbial interactions: from molecular mechanisms to precision therapy for IBD/IBS. J Neuroinflammation. 2025; 22: 172.

[23]

Wu YL, Zhang CH, Teng Y, Pan Y, Liu NC, Liu PX, et al. Propionate and butyrate attenuate macrophage pyroptosis and osteoclastogenesis induced by CoCrMo alloy particles. Mil Med Res. 2022; 9: 46.

[24]

Singh N, Gurav A, Sivaprakasam S, Brady E, Padia R, Shi H, et al. Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity. 2014; 40: 128-39.

[25]

McBride DA, Dorn NC, Yao M, Johnson WT, Wang W, Bottini N, et al. Short-chain fatty acid-mediated epigenetic modulation of inflammatory T cells in vitro. Drug Deliv Transl Res. 2023; 13: 1912-24.

[26]

Kimura I, Inoue D, Maeda T, Hara T, Ichimura A, Miyauchi S, et al. Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41). Proc Natl Acad Sci U S A. 2011; 108: 8030-5.

[27]

Paine LW, Higham JP, Barker KH, Pavlou S, Welsh F, Smith ESJ, et al. IL-17 Stimulates Sensory Neurons and Sensitises Colonic Afferents to Noxious Stimuli in a PI3K Dependent Manner in Male Mice. J Neurochem. 2025; 169: e70191.

[28]

Ju X, Jiang Z, Ma J, Yang D. Changes in Fecal Short-Chain Fatty Acids in IBS Patients and Effects of Different Interventions: A Systematic Review and Meta-Analysis. Nutrients. 2024; 16: 1727.

[29]

Baxter NT, Schmidt AW, Venkataraman A, Kim KS, Waldron C, Schmidt TM. Dynamics of Human Gut Microbiota and Short-Chain Fatty Acids in Response to Dietary Interventions with Three Fermentable Fibers. mBio. 2019; 10: 10.1128/mbio.02566-18.

[30]

Alles MS, Katan MB, Salemans JM, Van Laere KM, Gerichhausen MJ, Rozendaal MJ, et al. Bacterial fermentation of fructooligosaccharides and resistant starch in patients with an ileal pouch-anal anastomosis. Am J Clin Nutr. 1997; 66: 1286-92.

[31]

O’Keefe SJ, Ou J, Delany JP, Curry S, Zoetendal E, Gaskins HR, et al. Effect of fiber supplementation on the microbiota in critically ill patients. World J Gastrointest Pathophysiol. 2011; 2: 138-45.

[32]

Chambers ES, Viardot A, Psichas A, Morrison DJ, Murphy KG, Zac-Varghese SE, et al. Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults. Gut. 2015; 64: 1744-54.

[33]

Clarke JM, Topping DL, Christophersen CT, Bird AR, Lange K, Saunders I, et al. Butyrate esterified to starch is released in the human gastrointestinal tract. Am J Clin Nutr. 2011; 94: 1276-83.

[34]

Huang F, Guo A, Liu S, Liu H, Zhang Z, Lin T, et al. Gut microbiota-derived propionate alleviate traumatic painful neuroma through inhibiting the RIG-I-NF-κB-mediated neuroinflammation. Food Res Int. 2026; 226: 118087.

[35]

Sashide Y, Utugi S, Takeda M. A Short-Chain Fatty Acid, Butyrate, Suppresses the Hyperexcitability of Rat Nociceptive Primary Neurons Involved in Inflammatory Hyperalgesia. Molecules. 2025; 30: 2407.

[36]

Lanza M, Filippone A, Casili G, Giuffrè L, Scuderi SA, Paterniti I, et al. Supplementation with SCFAs Re-Establishes Microbiota Composition and Attenuates Hyperalgesia and Pain in a Mouse Model of NTG-Induced Migraine. Int J Mol Sci. 2022; 23: 4847.

PDF (1113KB)

18

Accesses

0

Citation

Detail

Sections
Recommended

/

〈 〉